Generation of tissue-specific H-2Kd transgenic mice for the study of Kd-restricted malaria epitope-specific CD8+ T-cell responses in vivo

Journal of Immunological Methods

Volumn 387, Issue 1-2, 2013, Pages 254-261

  Huang, Jing ^a   Li, Xiangming ^a   Kohno, Kenji ^b   Hatano, Masahiko ^c   Tokuhisa, Takeshi ^c   Murray, Peter J ^d   Brocker, Thomas ^e   Tsuji, Moriya ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antigen presenting cells; CD8+ T cells; H 2Kd; Malaria; Tissue specific; Transgenic mice

Indexed keywords

EPITOPE; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; IN VIVO STUDY; LIVER CELL; MACROPHAGE; MALARIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-PRESENTING CELLS; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; H-2 ANTIGENS; HEPATOCYTES; IMMUNIZATION; INTERFERON-GAMMA; MACROPHAGES; MALARIA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; OLIGOPEPTIDES; PLASMODIUM YOELII; PROTOZOAN PROTEINS; VACCINES, SUBUNIT;

ADENOVIRIDAE; MUS; MUS MUSCULUS; PLASMODIUM YOELII;

EID: 84871414875     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.10.019     Document Type: Article

References (31)

1. + T cells in vitro. J. Immunol. 2007, 178:7054.
2. Brocker T., Riedinger M., Karjalainen K. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 1997, 185:541.
3. + T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat. Med. 2007, 13:1035.
4. Crompton P.D., Pierce S.K., Miller L.H. Advances and challenges in malaria vaccine development. J. Clin. Invest. 2010, 120:4168.
5. + T cell immunity. Science 2011, 334:475.
6. Ferreira A., Schofield L., Enea V., Schellekens H., van der Meide P., Collins W.E., Nussenzweig R.S., Nussenzweig V. Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science 1986, 232:881.
7. Herz J., Gerard R.D. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:2812.
8. Huard J., Lochmüller H., Acsadi G., Jani A., Massie B., Karpati G. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther. 1995, 2:107.
9. + T cells against liver-stage malaria. PLoS One 2009, 4:e5075.
10. + T cells by exogenous cell-associated antigens. Immunity 2002, 17:211.
11. Kamphorst A.O., Guermonprez P., Dudziak D., Nussenzweig M.C. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes. J. Immunol. 2010, 185:3426.
12. Lloyd C.M., Phillips A.R., Cooper G.J., Dunbar P.R. Three-colour fluorescence immunohistochemistry reveals the diversity of cells staining for macrophage markers in murine spleen and liver. J. Immunol. Methods 2008, 334:70.
13. Mellouk S., Green S.J., Nacy C.A., Hoffman S.L. IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an l-arginine-dependent effector mechanism. J. Immunol. 1991, 146:3971.
14. Renia L., Rodrigues M.M., Nussenzweig V. Intrasplenic immunization with infected hepatocytes: a mouse model for studying protective immunity against malaria pre-erythrocytic stage. Immunology 1994, 82:164.
15. + cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int. Immunol. 1991, 3:579.
16. + T cell-mediated protective immunity against malaria. J. Immunol. 1997, 158:1268.
17. Roestenberg M., McCall M., Hopman J., Wiersma J., Luty A.J., van Gemert G.J., van de Vegte-Bolmer M., van Schaijk B., Teelen K., Arens T., et al. Protection against a malaria challenge by sporozoite inoculation. N. Engl. J. Med. 2009, 361:468.
18. Romero P., Maryanski J.L., Corradin G., Nussenzweig R.S., Nussenzweig V., Zavala F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 1989, 341:323.
19. Saito M., Iwawaki T., Taya C., Yonekawa H., Noda M., Inui Y., Mekada E., Kimata Y., Tsuru A., Kohno K. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat. Biotechnol. 2001, 19:746.
20. Sano G., Hafalla J.C., Morrot A., Abe R., Lafaille J.J., Zavala F. Swift development of protective effector functions in naive CD8(+) T cells against malaria liver stages. J. Exp. Med. 2001, 194:173.
21. + T cells and antibodies required for immunity to malaria sporozoites. Nature 1987, 330:664.
22. Schreiber T., Ehlers S., Heitmann L., Rausch A., Mages J., Murray P.J., Lang R., Hölscher C. Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J. Immunol. 2009, 183:1301.
23. + T cell immunity in vivo. J. Immunol. 2012, 189:2274.
24. Takao S., Sakai N., Hatano M., Koizumi T., Hanioka K., Rüther U., Tokuhisa T. IgG response is impaired in H2-c-fos transgenic mice. Int. Immunol. 1991, 3:369.
25. Tamminga C., Sedegah M., Regis D., Chuang I., Epstein J.E., Spring M., Mendoza-Silveiras J., McGrath S., Maiolatesi S., Reyes S., et al. Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component. PLoS One 2011, 6:e25868.
26. Trumpfheller C., Longhi M.P., Caskey M., Idoyaga J., Bozzacco L., Keler T., Schlesinger S.J., Steinman R.M. Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity. J. Intern. Med. 2012, 271:183.
27. + T-cell responses in mice after immunization with recombinant viruses. Methods Mol. Med. 2002, 72:361.
28. Tsuji M., Miyahira Y., Nussenzweig R.S., Aguet M., Reichel M., Zavala F. Development of antimalaria immunity in mice lacking IFN-gamma receptor. J. Immunol. 1995, 154:5338.
29. + T-cell activation after viral infection. Nature 2011, 471:629.
30. + T lymphocytes in primates immunized with malaria sporozoites. PLoS One 2012, 7:e31247.
31. + T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:573.